Insulin aspart, recombinant Subcutaneous and Sucroferric oxyhydroxide
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Sucroferric oxyhydroxide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: sucroferric oxyhydroxide
Brand name: Velphoro
Synonyms: Sucroferric Oxyhydroxide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Sudafed
- Insulin aspart, recombinant Subcutaneous-Sudafed 12 Hour
- Insulin aspart, recombinant Subcutaneous-Sudafed 12 Hour Pressure + Pain
- Insulin aspart, recombinant Subcutaneous-Sudafed 24 Hour
- Insulin aspart, recombinant Subcutaneous-Sudafed Childrens
- Insulin aspart, recombinant Subcutaneous-Sudafed OM Sinus Cold
- Sucroferric oxyhydroxide-Insulin degludec
- Sucroferric oxyhydroxide-Insulin Degludec (U-100) Prefilled Pens
- Sucroferric oxyhydroxide-Insulin Degludec (U-100) Vials
- Sucroferric oxyhydroxide-Insulin Degludec (U-200) Prefilled Pens
- Sucroferric oxyhydroxide-Insulin degludec and liraglutide
- Sucroferric oxyhydroxide-Insulin degludec and liraglutide Subcutaneous